Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors - Takeaways - MDSpire

Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors

  • By

  • Sebastian Galeano

  • Carmem Bonfim

  • Amado Karduss

  • Gregorio Jaimovich

  • Andrés Gómez-De León

  • Gustavo Bettarello

  • Anderson Simione

  • Cinthya Correa

  • Helen Baldomero

  • Daniel Neumann

  • Ana Lisa Basquiera

  • Mariano Berro

  • Guillermina Remaggi

  • Ariel Amaru

  • Fernando Barroso

  • Adriana Seber

  • Francisco Barriga

  • Julia Palma

  • Bárbara Puga

  • Matías Sánchez

  • Juan Manuel Herrera

  • Calixto Hernández

  • David Gómez-Almaguer

  • Félix Gaytán Morales

  • Guillermo J. Ruiz-Argüelles

  • Ninotzka Mendoza

  • María Liz Benítez

  • Alfredo Wong

  • Carolina Pagés

  • Marcos Hernández

  • Dietger Niederwieser

  • Damiano Rondelli

  • Cristóbal Frutos

  • April 18, 2025

  • 0 min

Share

  • 1

    The LABMT conducted a survey from 2019-2022 to assess hematopoietic stem cell transplantation (HCT) activity across 15 Latin American countries.

  • 2

    A total of 6767 first HCTs were reported in 2022, with 39% being allogeneic and 61% autologous transplants.

  • 3

    Pediatric HCTs accounted for 1121 cases in 2022, with 82% being allogeneic and 18% autologous.

  • 4

    The transplant rate in Latin America for 2022 was 103 HCTs per 10 million population, with 63 autoHCTs and 40 alloHCTs.

  • 5

    The survey highlighted an increase in haploidentical donors, reflecting a significant trend in donor types for allogeneic transplants.

Original Source(s)

Related Content